BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/12/2025 3:45:49 AM | Browse: 3 | Download: 0
 |
Received |
|
2025-03-04 07:56 |
|
Peer-Review Started |
|
2025-03-04 07:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-03-26 21:08 |
|
Revised |
|
2025-04-03 03:35 |
|
Second Decision |
|
2025-04-24 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-04-24 06:56 |
|
Articles in Press |
|
2025-04-24 06:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-05-30 03:36 |
|
Publish the Manuscript Online |
|
2025-06-12 03:45 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Reevaluating therapeutic strategies in Crohn’s disease: Comparing Modulen and budesonide
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chloe Lahoud, Toni Habib, Elie Bou Sanayeh and Liliane Deeb |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Elie Bou Sanayeh, MD, Department of Internal Medicine, Staten Island University Hospital, 475 Seaview Avenue, New York, NY 10305, United States. elie.h.bousanayeh@gmail.com |
| Key Words |
Crohn’s disease; Modulen; Budesonide; Enteral nutrition; Therapeutic strategies |
| Core Tip |
Because of the need for effective treatments for mild to moderate Crohn’s disease, nutritional interventions like Modulen have been suggested as a potential option alongside pharmaceutical treatments. Nutritional therapy can improve clinical and endoscopic outcomes, though issues like taste intolerance and adherence remain challenges. Pharmaceutical treatments, such as budesonide, show promise in reducing inflammation, but they may be less effective for mucosal healing. Combining both approaches may offer better management for Crohn’s disease patients. More research is needed to explore long-term benefits and improve patient adherence to treatments. |
| Publish Date |
2025-06-12 03:45 |
| Citation |
<p>Lahoud C, Habib T, Bou Sanayeh E, Deeb L. Reevaluating therapeutic strategies in Crohn’s disease: Comparing Modulen and budesonide. <i>World J Gastroenterol</i> 2025; 31(22): 106636</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i22/106636.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i22.106636 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
